Massive Survey Aims to Assess CBD for Anxiety Relief
While the COVID-19 pandemic has ratcheted up anxiety levels, a new survey aims to assess the role CBD and other cannabinoids can play in helping Americans cope.
On Wednesday, the Wholistic Research and Education Foundation, a nonprofit dedicated to cannabis research and advocacy, announced the launch of its Cannabinoid Anxiety Relief Education Study, or CARES. Billed as the first study of its kind, researchers will contact millions of Americans in an effort to learn if and how cannabinoids help them reduce anxiety and co-morbid conditions, like insomnia and depression . . .
Log in or become a WeedWeek Member to read this article.
